Response Genetics (NASDAQ:RGDX) Report Narrower Loss in Fiscal Fourth Quarter – RGDX, MYGN, GHDX, LPDX

Response Genetics, Inc (NASDAQ:RGDX) announced on Thursday that fiscal Q4 net loss was narrowed to $0.5 million or $0.01 a share, from $3.9 million or $0.20 a share in the similar period a year earlier.

Total operating expenses for fiscal Q4 were $3.5 million without cost of revenue, evaluated against $5.2 million for the similar quarter in previous year. Quarterly total revenue was $5.5 million contrasted against $4.9 million in earlier year.

Thomson Reuters’ analysts survey most recently forecasted to announce a loss of $0.06 a share on $5.16 million of revenues for the quarter. Analysts’ forecasts usually exclude onetime items.

Shifting reader’s focus to broader market, let us consider market performance of other stocks that significantly affect same sector. Myriad Genetics, Inc. (NASDAQ:MYGN) rose +0.71% to settle at $25.49, Genomic Health, Inc. (NASDAQ:GHDX) moved down -0.54% to end at $27.74 while LipoScience Inc (NASDAQ:LPDX) jumped +0.89% to finish at $10.40 on Thursday.

Response Genetics, Inc. (NASDAQ:RGDX) last session’s volume of 70,323 shares was surprisingly higher than its average volume of 11,182 shares. The stock after opening at $1.32 hit high price of $1.35 and then closed at $1.35 by scoring +4.65%.

The liquidity measure in recent quarter results of the company was recorded 2.88 as current ratio. The Company had total cash of $10.84 million at hand and a book value per share as $-0.24 in the most recent quarter.

The stock’s price volatility was 7.56% for a week and 5.46% for a month as well as price volatility’s Average True Range for 14 days was 0.09 and its beta remained at 0.37.

RGDX generated revenue of $18.13 million in the previous twelve months and earned -$11.21 million. The Company showed a negative -61.84% in the net profit margin as well as in its operating margin which remained at -61.42%. Company’s annual sales growth for the past five years was 30.35%.

DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with! CLICK HERE TO START YOUR FREE 30-DAY TRIAL

This entry was posted in Healthcare, Main Post and tagged , , , , , , , , , , , . Bookmark the permalink.